Derivation & Validation of Glycosylated Haemoglobin (HbA ) Cut-off Value As a Diagnostic Test for Type 2 Diabetes in South Indian Population
Overview
Authors
Affiliations
Background & Objectives: Glycosylated haemoglobin (HbA 1c ) has been in use for more than a decade, as a diagnostic test for type 2 diabetes. Validity of HbA 1c needs to be established in the ethnic population in which it is intended to be used. The objective of this study was to derive and validate a HbA 1c cut-off value for the diagnosis of type 2 diabetes in the ethnic population of Rayalaseema area of south India.
Methods: In this cross-sectional study, consecutive patients suspected to have type 2 diabetes underwent fasting plasma glucose (FPG) and 2 h post-load plasma glucose (2 h-PG) measurements after a 75 g glucose load and HbA 1c estimation. They were classified as having diabetes as per the American Diabetes Association criteria [(FPG ≥7 mmol/l (≥126 mg/dl) and/or 2 h-PG ≥11.1 mmol/l (≥200 mg/dl)]. In the training data set (n = 342), optimum cut-off value of HbA 1c for defining type 2 diabetes was derived by receiver-operator characteristic (ROC) curve method using oral glucose tolerance test results as gold standard. This cut-off was validated in a validation data set (n = 341).
Results: On applying HbA 1c cut-off value of >6.3 per cent (45 mmol/mol) to the training data set,sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for diagnosing type 2 diabetes were calculated to be 90.6, 85.2, 80.8 and 93.0 per cent, respectively. When the same cut-off value was applied to the validation data set, sensitivity, specificity, PPV and NPV were 88.8 , 81.9, 74.0 and 92.7 per cent, respectively, although the latter were consistently smaller than the proportions for the training data set, the differences being not significant.
Interpretation & Conclusions: HbA 1c >6.3 per cent (45 mmol/mol) appears to be the optimal cut-off value for the diagnosis of type 2 diabetes applicable to the ethnic population of Rayalaseema area of Andhra Pradesh state in south India.
Ashtekar S, Deshmukh P, Ghaisas N, Ashtekar C, Upasani S, Kirloskar M Indian J Community Med. 2023; 48(1):91-97.
PMID: 37082386 PMC: 10112759. DOI: 10.4103/ijcm.ijcm_248_22.
Lazo-Porras M, Ruiz-Alejos A, Miranda J, Carrillo-Larco R, Gilman R, Smeeth L Diabet Med. 2020; 37(9):1519-1527.
PMID: 32181918 PMC: 7649719. DOI: 10.1111/dme.14298.
Radhakrishna P, Vinod K, Sujiv A, Swaminathan R Indian J Endocrinol Metab. 2018; 22(1):50-56.
PMID: 29535937 PMC: 5838911. DOI: 10.4103/ijem.IJEM_254_17.
Mohan A, Aparna Reddy S, Sachan A, Sarma K, Kumar D, Panchagnula M Indian J Med Res. 2017; 145(4):573-574.
PMID: 28862195 PMC: 5663177. DOI: 10.4103/0971-5916.213767.
Choice of criterion used in the receiver operating characteristic analysis.
Habibzadeh F, Habibzadeh P, Yadollahie M Indian J Med Res. 2017; 145(4):571-572.
PMID: 28862194 PMC: 5663176. DOI: 10.4103/ijmr.IJMR_2002_16.